EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma

Masatoshi Kudo

Liver Cancer · 2024 · 13 (2) · 113-118

DOI: 10.1159/000537897 ↗

Kurz gefasst

Editorial in der Zeitschrift Liver Cancer, online erschienen am 20.02.2024. Verfasst von Masatoshi Kudo. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Higashiosaka, Japan. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AFP-L3DCPHepatocellular carcinomaImmunotherapyPIVKA-II

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Higashiosaka, Japan.

Zitieren

APA

Kudo, M. (2024). Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma. Liver Cancer, 13(2), 113-118. https://doi.org/10.1159/000537897

Vancouver

Kudo M. Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma. Liver Cancer. 2024;13(2):113-118. doi:10.1159/000537897

BibTeX
@article{Kudo2024,
  author = {Kudo, Masatoshi},
  title = {Urgent Global Need for PIVKA-II and AFP-L3 Measurements for Surveillance and Management of Hepatocellular Carcinoma},
  journal = {Liver Cancer},
  year = {2024},
  volume = {13},
  number = {2},
  pages = {113--118},
  doi = {10.1159/000537897}
}
Kostenlos starten →